From environmental disasters to emerging drugs; a framework to understand, map and assess drug-related early warning systems

Unregulated drug markets are fast expanding and increasingly mediated through digital technologies. In a context of drug prohibition, the composition, potency and effects of substances are not guaranteed which can expose people to potentially fatal risks. There are pronounced concerns about the harms posed by substances such as synthetic opioids like fentanyl and nitazenes. The coordinated activities of stakeholders who attempt to identify, prepare for and mitigate rapidly emerging drug-related harms are often collectively described as early warning systems (EWSs). EWSs are not exclusive to the drugs field. The conceptual underpinnings and implementation strategies associated with EWSs are thoroughly documented in international guidelines surrounding environmental disaster risk reduction. These guidelines suggest that EWSs incorporate four interconnected subcomponents, [1] risk knowledge, [2] detection monitoring and forecasting, [3] response capability and [4] warning communication. In this commentary we outline the data sources, processes, stakeholders, and outputs involved in the operation of modern drug-related EWSs and consider the extent to which practices align with these four components. In doing so, we consider the ways in which routine drug monitoring and horizon scanning may bolster drug-related EWSs and outline the imperative to meaningfully involve people who use drugs within data collection, interpretation and response processes. Our proposed framework, which outlines the components of drug-related EWSs, is designed to support efforts to devise, describe, evaluate and locally tailor EWSs across diverse jurisdictions.

Authors

Institutions

Publication Details

Journal
International Journal of Drug Policy
Published
2025-08-11
DOI
https://doi.org/10.1016/j.drugpo.2025.104946
Citations
4
Primary Topic
Data-Driven Disease Surveillance
Type
article
Field-Weighted Citation Impact
5.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

From environmental disasters to emerging drugs; a framework to understand, map and assess drug-related early warning systems

Rachel Sutherland, Helen Macdonald, Kylie Fletcher, Brendan Clifford et al.
4 citations
International Journal of Drug Policy
Data-Driven Disease Surveillance
5.42
article

From environmental disasters to emerging drugs; a framework to understand, map and assess drug-related early warning systems

Rachel Sutherland, Helen Macdonald, Kylie Fletcher, Brendan Clifford, Nadine Ezard, Michael J. Barratt, Krista J. Siefried, Amy Peacock, Liam Acheson, Julie Freestone, Jess Doumany, Stassi Kypri
article en
4 citations

Abstract

Unregulated drug markets are fast expanding and increasingly mediated through digital technologies. In a context of drug prohibition, the composition, potency and effects of substances are not guaranteed which can expose people to potentially fatal risks. There are pronounced concerns about the harms posed by substances such as synthetic opioids like fentanyl and nitazenes. The coordinated activities of stakeholders who attempt to identify, prepare for and mitigate rapidly emerging drug-related harms are often collectively described as early warning systems (EWSs). EWSs are not exclusive to the drugs field. The conceptual underpinnings and implementation strategies associated with EWSs are thoroughly documented in international guidelines surrounding environmental disaster risk reduction. These guidelines suggest that EWSs incorporate four interconnected subcomponents, [1] risk knowledge, [2] detection monitoring and forecasting, [3] response capability and [4] warning communication. In this commentary we outline the data sources, processes, stakeholders, and outputs involved in the operation of modern drug-related EWSs and consider the extent to which practices align with these four components. In doing so, we consider the ways in which routine drug monitoring and horizon scanning may bolster drug-related EWSs and outline the imperative to meaningfully involve people who use drugs within data collection, interpretation and response processes. Our proposed framework, which outlines the components of drug-related EWSs, is designed to support efforts to devise, describe, evaluate and locally tailor EWSs across diverse jurisdictions.

International Journal of Drug PolicyVol. 145
Alcohol and Drug Foundation (AU), UNSW Sydney (AU), National Centre for Clinical Research on Emerging Drugs (AU)
Climate action
Openalex Percentile: Top 4%
Data-Driven Disease Surveillance
5.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.